Literature DB >> 16395111

Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy.

Joerg Faber1, Claudius U Meyer, Christina Gemmer, Alexandra Russo, Adam Finn, Craig Murdoch, Werner Zenz, Christine Mannhalter, Bernhard U Zabel, Heinz-J Schmitt, Pirmin Habermehl, Fred Zepp, Markus Knuf.   

Abstract

Toll-like receptor 4 (TLR4) is required for efficient recognition of bacterial infections. We investigated an association between 2 TLR4 mutations (Asp(299)Gly and Thr(399)Ile) and meningococcal disease in 197 patients and 214 healthy controls by allele-specific real time polymerase chain reaction and direct sequencing. Although the allele frequency was not higher in the overall patient population, a significantly higher frequency in the 40 patients younger than 12 months of age (P = 0.007) was observed. We conclude that TLR4 mutations represent a risk factor for meningococcal disease in this age group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395111     DOI: 10.1097/01.inf.0000195595.22547.fe

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  27 in total

Review 1.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

2.  Optimal CD8 T-cell response against Encephalitozoon cuniculi is mediated by Toll-like receptor 4 upregulation by dendritic cells.

Authors:  Elizabeth M Lawlor; Magali M Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

Review 3.  Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Arshad
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

4.  The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.

Authors:  Floris Fransen; Hendrik Jan Hamstra; Claire J Boog; Jos P van Putten; Germie P J M van den Dobbelsteen; Peter van der Ley
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

Review 5.  The role of Toll-like receptor 4 polymorphisms in vaccine immune response.

Authors:  P Pellegrino; F S Falvella; S Cheli; C Perrotta; E Clementi; S Radice
Journal:  Pharmacogenomics J       Date:  2015-03-31       Impact factor: 3.550

Review 6.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

7.  TLRs, SNPs and VLBWs: oh my!

Authors:  J L Wynn
Journal:  J Perinatol       Date:  2013-10       Impact factor: 2.521

8.  Meningococcal outer membrane protein NhhA is essential for colonization and disease by preventing phagocytosis and complement attack.

Authors:  Hong Sjölinder; Jens Eriksson; Lisa Maudsdotter; Helena Aro; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

9.  Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.

Authors:  Hong Sjölinder; Trine H Mogensen; Mogens Kilian; Ann-Beth Jonsson; Søren R Paludan
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

10.  CD14 C-159T and toll-like receptor 4 Asp299Gly polymorphisms in surviving meningococcal disease patients.

Authors:  Ariane Biebl; Axel Muendlein; Zhyrgal Kazakbaeva; Sigrid Heuberger; Gudrun Sonderegger; Heinz Drexel; Susanne Lau; Renate Nickel; Michael Kabesch; Burkhard Simma
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.